Company: AEGOF
Filing Date: 2025-08-21
Form Type: 6-K
Source: 0001193125-25-184596
Chunk: 9

Company: AEGON LTD.
Filing Date: 2025-08-21
Form: 6-K
Chunk 9
---
  (104 | ) |     |   | n.m. |   |
| Average common shareholders’ equity                                            |     |       |    |     |         | 7,329 |   |     |         | 7,103 |   |     |   |    3 |   |
| Return on Equity                                                               |     |       | 11 |     |         |  17.6 | % |     |         |  15.1 | % |     |   |      |   |

The gain from non-operatingitems amounted to EUR 95 million in the first half of 2025, mainly due to fair value gains. Fair value items Fair value items constituted a gain of EUR 154 million, mostly from positive hedge results. In the Americas, the hedging of guarantees in the Variable Annuities, Indexed Universal Life and RILA blocks led to overall positive results, partly offset by market driven fair value losses. Furthermore, the Holding contributed favorably, driven by interest rate hedges related to debt instruments. 15

In addition, there were fair value gains from mark-to-marketrevaluations related to TLB, including from the annual assumption updates. These were largely offset by losses in Other Comprehensive Income. Realized losses on investments Realized losses on investments amounted to EUR 54 million and were driven by the Americas. There, targeted bond sales resulted in losses, which were partly offset by gains from ECL reversals on disposed bonds. Net impairments Net impairments were limited and amounted to EUR 5 million for the reporting period. Other charges Other charges amounted to EUR 207 million, mainly driven by the annual assumption updates in the Americas and TLB, the impact of which amounted to EUR 183 million. The impact was mainly from strengthening lapse assumptions to address recent adverse experience in the Financial Assets book, driven by the TLB Universal Life block reinsured to Transamerica and Variable Annuities. In Protection Solutions, assumption updates mainly related to an update of Medicare Supplement morbidity assumptions to address an industry-wide trend. Other charges also included the positive result from Aegon’s stake in a.s.r. of EUR 50 million. Furthermore, it included restructuring charges and investments to transform the business mainly in the UK and in the Americas. Net result The result before tax amounted to EUR 733 million, as the positive impacts from the operating result and non-operatingitems were only partly offset by Other charges. The income tax for the period amounted to EUR 127 million